| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |